GOUT CHRONIC
Clinical trials for GOUT CHRONIC explained in plain language.
Never miss a new study
Get alerted when new GOUT CHRONIC trials appear
Sign up with your email to follow new studies for GOUT CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough gout cases: experimental combo targets stubborn uric acid
Disease control Recruiting nowThis study tests a new drug called AR882 combined with a standard gout medication (XOI) in 25 adults with uncontrolled gout who had severe reactions or failed uricase therapy. The goal is to lower uric acid levels below 6 mg/dL and shrink painful uric acid crystal deposits (tophi…
Matched conditions: GOUT CHRONIC
Phase: PHASE2 • Sponsor: Arthrosi Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New gout drug combo under the microscope: ABP-671 meets allopurinol
Knowledge-focused Recruiting nowThis study looks at how a new drug, ABP-671, interacts with the standard gout medication allopurinol. About 20 adults with gout who are already taking allopurinol will receive ABP-671 as well. Researchers will measure drug levels in the blood to see if there are any interactions,…
Matched conditions: GOUT CHRONIC
Phase: PHASE1 • Sponsor: Atom Therapeutics Co., Ltd • Aim: Knowledge-focused
Last updated May 17, 2026 06:22 UTC